
















Antiproliferative effect of the HSP90 inhibitor 
NVP-AUY922 is determined by the expression of PTEN 






Heat shock protein 90 (HSP90)， a molecular chaperone， has provoked great interest as a 
promising molecular t釘'getfor cancer treatment， due to its involvement in regulating the conformation， 
stabiJity and functions of key oncogenic proteins. At present， a variety of chemical compounds 
targeting HSP90 have been developed and have shown convincing anti-neoplastic activity in various 
preclinical tumor models. The aim of our study was to evaluate the antitumor effects of a novel HSP90 
inhibitor， NVP・AUY922，in esophageal squamous cancer cells (ESCC). Four ESCC cel Iines (TE・1，
TE・4，TE・8，TE・10)were examined. NVP・AUY922potently inhibited the proliferation of ESCC， 
particularly in PTEN・nullTE・4cells with a 2・3times lower ICso than the other three cel lines. 
Western blot analysis showed that PTEN・nullTE・4celJs exhibited higher AKT and ERK activity， 
which contribute to cel proliferation and survival. NVP-AUY922 significantly suppressed the activity 
of AKT and ERK in TE-4 but not in PTEN-proficient TE・10.Genetic modification experiments 
demonstrated that the sensitivity to NVP-AUY922 was decreased by exogenous transduction ofPTEN 
in TE・4and increa包edby silencing PTEN expression in intact PTEN醐expressingTE-10， suggesting 
that the expression of PTEN may be associated with ceJl sensitivity in HSP90 inhibition. Furthermore， 
the enhanced activity of AKT in PTEN-silenced TE・10was more easily suppressed by NVP-AUY922. 
Collectively， NVP-AUY922 exhibits a strong antiproliferative effect， revealing its potential as a novel 







特に TE-4細胞株で効果が顕著であった。 TE-4細胞株における HSP90阻
害剤の効果の機序を検討したところ、この細胞株では PTENの発現が消失
していた。PTENの発現と HSP90阻害剤の関係を、siRNAやtransduction
を用いて検討したところ、 PTENの発現低下が ARKの発現増強をもたら
し、 HSP90阻害剤の感受性を高めることが明らかになった。
本研究は、食道癌細胞株において、 PTENの発現状態が HSP90阻害剤
の効果を規定することを明らかにした点で興味深い。
よって本研究者は博士(医学)の学位を得る資格があると認める。
要の論文審査結果
